Filter By Industry
Filter By Tag

Newsroom

Huateng Pharma Press releases

1 - 10 of 51 Press Releases

Jan 17, 2025
Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) II registration with the U.S.

Oct 23, 2024
Hunan Huateng Pharmaceutical Co., Ltd. is proud to provide high-quality monodispersed polyethylene glycols (PEGs) tailored for the evolving needs of antibody-drug conjugates (ADCs).

Sep 28, 2024
Huateng Pharma, a leading supplier of PEG derivatives and trusted CDMO partner, is thrilled to announce its participation in CPhI Worldwide 2024, scheduled for October 14-16 in Milan, Italy.

Aug 20, 2024
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce its comprehensive range of services catering to Veterinary APIs, Pharmaceutical Intermediates, Cosmetic Ingredients, and Specialty & Fine...

Jul 23, 2024
Huateng Pharma, a global leader in PEG derivatives and a premier CDMO for APIs and intermediates, is excited to announce the launch of its latest product, Y-Shape PEG NHS.

Jun 16, 2024
Hunan Huateng Pharmaceutical Co., Ltd., a global leader in the production of PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services for Active Pharmaceutical Ingredients (APIs) and intermediates, is excited to announce...

May 20, 2024
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce the launch of its latest product, Piroctone Olamine.

Mar 20, 2024
Hunan Huateng Pharmaceutical Co., Ltd, a global leader in PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services, cordially invites you to visit our booth at CPhI Japan 2024, held from April 17th to 19th at Tokyo Big...

Feb 29, 2024
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain.

Jan 17, 2024
Huateng Pharma, a Contract Development and Manufacturing Organization (CDMO) specializing in APIs and intermediates, is proud to announce its featured product line catering specifically to the veterinary industry.


Page: 1 2 3 4 5 Next
Huateng Pharma RSS Feed